Literature DB >> 28523175

A chronic thromboembolic pulmonary hypertension catch-22 situation: inferior vena caval filter plays a pivotal role in an unlikely situation.

Karthik Seetharam1, Elbert E Williams1, Elizabeth Oswald1, Ramachandra Reddy1.   

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare clinical entity that occurs in a small subset of acute pulmonary embolism (PE) cases and is surgically cured by pulmonary endarterectomy. We report a case of a 44-year-old female with a complex history of CTEPH treated by thromboendarterectomy who presented with a subdural hematoma while on warfarin. The patient eventually recovered by a multidisciplinary approach, use of inferior vena caval filter, and effective anticoagulation management.

Entities:  

Keywords:  Pulmonary embolism (PE); inferior vena caval filter; pulmonary hypertension; thromboendarterectomy

Year:  2017        PMID: 28523175      PMCID: PMC5418289          DOI: 10.21037/jtd.2017.03.67

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  8 in total

Review 1.  Chronic major-vessel thromboembolic pulmonary hypertension.

Authors:  K M Moser; W R Auger; P F Fedullo
Journal:  Circulation       Date:  1990-06       Impact factor: 29.690

2.  Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study.

Authors: 
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

3.  Reoperative pulmonary thromboendarterectomy.

Authors:  M Mo; D P Kapelanski; S N Mitruka; W R Auger; P F Fedullo; R N Channick; K Kerr; C Archibald; S W Jamieson
Journal:  Ann Thorac Surg       Date:  1999-11       Impact factor: 4.330

Review 4.  Technical advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.

Authors:  Michael M Madani; Stuart W Jamieson
Journal:  Semin Thorac Cardiovasc Surg       Date:  2006

Review 5.  The role of vena caval filters in the management of venous thromboembolism.

Authors:  Christine L Hann; Michael B Streiff
Journal:  Blood Rev       Date:  2005-07       Impact factor: 8.250

Review 6.  Vena cava filters for management of venous thromboembolism: a clinical review.

Authors:  Anita Rajasekhar; Michael B Streiff
Journal:  Blood Rev       Date:  2013-08-07       Impact factor: 8.250

7.  Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

Authors:  Vittorio Pengo; Anthonie W A Lensing; Martin H Prins; Antonio Marchiori; Bruce L Davidson; Francesca Tiozzo; Paolo Albanese; Alessandra Biasiolo; Cinzia Pegoraro; Sabino Iliceto; Paolo Prandoni
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

Review 8.  NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank.

Authors:  James A Reiffel; Jeffrey I Weitz; Paul Reilly; Edvardas Kaminskas; Troy Sarich; Philip Sager; Jonathan Seltzer
Journal:  Am Heart J       Date:  2016-04-23       Impact factor: 4.749

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.